26 and the references therein), they have limitations associated with well-known multiple adverse reactions, genotoxicity, and special requirements for storage, handling, and administration, posing challenges with respect to the standard operating procedure (SOP) for MDA campaigns requiring single or double dose activity, oral administration, minimal toxicity, and stability in tropical settings 27
Schisselbauer JC, Silber R, Papadoupoulos E, Abrams K, LaCreta FP and Tew KD
It expands access to GLP-1s beyond those with clinical obesity recognizing their potential benefits beyond weight alone
[13] First-line management according to US guidelines, including those from the Endocrine Society and American Society for Reproductive Medicine, emphasizes lifestyle modification for weight reduction
Saudi.Med.J 2010;31(8):931-934
doi:10.1210/clinem/dgz047 AdipoGen Life Science